These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1003712)

  • 21. Effects of chronic amphetamine in BALB/cBy mice, a strain that is not stimulated by acute administration of amphetamine.
    Logan L; Seale TW; Cao W; Carney JM
    Pharmacol Biochem Behav; 1988 Nov; 31(3):675-82. PubMed ID: 3251250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 23. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior.
    Mohammed AK; Danysz W; Ogren SO; Archer T
    Neurosci Lett; 1986 Feb; 64(2):139-44. PubMed ID: 3008041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between (+)- and (-)-amphetamine in effects on locomotor activity and L-dopa potentiating action in mice.
    Strömberg U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):171-9. PubMed ID: 1143358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central effects of scopolamine and (+)-amphetamine on locomotor activity: interaction with strain and stress variables;
    Anisman H; Cygan D
    Neuropharmacology; 1975 Nov; 14(11):835-40. PubMed ID: 1207879
    [No Abstract]   [Full Text] [Related]  

  • 27. Amphetamine withdrawal: a behavioral evaluation.
    Kokkinidis L; Zacharko RM; Anisman H
    Life Sci; 1986 Apr; 38(17):1617-23. PubMed ID: 3702594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 29. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.
    Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
    Neuroscience; 1998 Oct; 86(3):959-65. PubMed ID: 9692731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory locomotor response habituation: dissociable effects of (+)-amphetamine and (-)-amphetamine [proceedings].
    Bell R; Cooper SJ
    Br J Pharmacol; 1978 Mar; 62(3):399P. PubMed ID: 638329
    [No Abstract]   [Full Text] [Related]  

  • 31. Facilitation of stimulatory effect of chlordiazepoxide-amphetamine combination by subacute administration of chlordiazepoxide in mice.
    Sansone M; Renzi P; Vetulani J
    Psychopharmacology (Berl); 1986; 89(1):52-4. PubMed ID: 3090591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule-induced polydipsia experience decreases locomotor response to amphetamine.
    Tazi A; Dantzer R; Le Moal M
    Brain Res; 1988 Apr; 445(2):211-5. PubMed ID: 3370459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse.
    Crawford CA; Drago J; Watson JB; Levine MS
    Neuroreport; 1997 Jul; 8(11):2523-7. PubMed ID: 9261820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locomotor responses of FAST and SLOW mice to several alcohols and drugs of abuse.
    Phillips TJ; Burkhart-Kasch S; Gwiazdon CC; Crabbe JC
    Ann N Y Acad Sci; 1992 Jun; 654():499-501. PubMed ID: 1632613
    [No Abstract]   [Full Text] [Related]  

  • 35. Aggression in mice after p-chloroamphetamine.
    Gianutsos G; Lal H
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):379-82. PubMed ID: 1171509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM; Mogenson GJ
    Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):75-83. PubMed ID: 5673717
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of thyroid hormones on the action of some centrally acting drugs.
    Coville PF; Telford JM
    Br J Pharmacol; 1970 Dec; 40(4):747-58. PubMed ID: 5531341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of amphetamine on locomotion depends on the motor device utilized. The open field vs. the running wheel.
    Della Maggiore V; Ralph MR
    Pharmacol Biochem Behav; 2000 Apr; 65(4):585-90. PubMed ID: 10764910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    J Pharm Pharmacol; 1984 Feb; 36(2):127-30. PubMed ID: 6143801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.